Advanced Diagnostics, applying Molecular Diagnostics and Immunodiagnostics technologies, are used for a variety of clinical purposes from research to clinical decision-making. These include screening for disease, diagnosis, prognosis, therapy selection and prediction of therapeutic benefits, monitoring risk of recurrence risk as well as support in  clinical trials designs.

The technologies used are state-of-the-art and constantly evolving, such as gene expression profiling, immune sequencing and liquid biopsy methods for detecting mutations in cell free tumor DNA (ct-DNA).

In this way it is possible to map and find biomarkers for effective "personalized therapy", what is described as Precision Medicine.